Anti-ABCA1 antibody [AB.H10] (ab18180) is a mouse monoclonal antibody detecting ABCA1 in Western Blot, Flow Cytometry, IHC-P. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Over 200 publications
- Trusted since 2005
View Alternative Names
ABC1, CERP, ABCA1, Phospholipid-transporting ATPase ABCA1, ATP-binding cassette sub-family A member 1, ATP-binding cassette transporter 1, Cholesterol efflux regulatory protein, ABC-1, ATP-binding cassette 1
- Flow Cyt
Unknown
Flow Cytometry - Anti-ABCA1 antibody [AB.H10] (AB18180)
Overlay histogram showing HepG2 cells stained with ab18180 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab18180, 2μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 4% paraformaldehyde/permeabilized in 0.1% PBS-Tween used under the same conditions.
- WB
Supplier Data
Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
The lower bands are from the secondary anti-mouse antibody reacting to the endogenous mouse antibodies from the tissue.
All lanes:
Western blot - Anti-ABCA1 antibody [AB.H10] (ab18180) at 1/1000 dilution
Lanes 1, 3 and 5:
Wild type mouse liver tissue lysate at 100 µg
Lanes 2, 4 and 6:
Knockout mouse liver tissue lysate at 100 µg
Predicted band size: 254 kDa
Observed band size: 254 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ABCA1 antibody [AB.H10] (AB18180)
Immunoreactivity of pancreas tissue for ABCA1 protein. Left panel : strong immunopositivity of exocrine glandular cells of the pancreas, especially in the basal region (arrows). Interstitial microvascular cells are apparently negative. Cells within the islet were weakly positive (data not shown). Right panel : the negative control. Hematoxylin counterstain.
- WB
CiteAb
Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Rao, G. N. et al., 2015, Nat Commun, 26104863. Legend direct from paper.
The lack of Pak1 diminishes monocyte adhesion to the aorta.(a) Aortas from 24-week-old ApoE−/− mice were incubated with BCECF-labelled monocytes from C57BL/6 and Pak1−/− mice, and the adherent monocytes were observed under a fluorescent microscope and counted. (b) Aortas from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were incubated with BCECF-labelled monocytes from C57BL/6 mice and the adherent cells were observed under a fluorescent microscope and counted. (c) Peritoneal macrophages from WT, ApoE−/− and Pak1−/− mice were treated with and without cholesterol (40 µg ml−1), IL-6 (20 ng ml−1) or MCP-1 (50 ng ml−1) for 6 h and cell extracts were prepared. Equal amounts of protein from control and each treatment were analysed by western blotting for CD36 and ABCA1 levels using their specific antibodies and normalized for β-tubulin. Bar graphs in a and b represent three independent experiments with three mice per group per experiment. Data were presented as mean±s.d. and assessed by Student's t-test. *P<0.01 versus WT or ApoE−/− mice. Scale bars, 20 µm (a,b).
false
- WB
CiteAb
Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Rao, G. N. et al., 2015, Nat Commun, 26104863. Legend direct from paper.
Pak1 regulates SMC migration and lesion formation.Aortic SMCs from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were isolated, cultured and tested for their purity using anti-SMCα-actin antibodies (a), analysed for IL-6 expression by FACS (b) and subjected to wound-healing migration assay (c). (d) Aortic SMC extracts from ApoE−/− and ApoE−/− : Pak1−/− mice were analysed by western blotting for the indicated proteins using their specific antibodies. FACS analysis of CD36 expression (e) and Dil-OxLDL uptake (f) are shown. SMCs isolated from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were either incubated with OxLDL or Dil-OxLDL for 6 h and stained with Oil red O (g, left panel) or observed under fluorescent microscope (g, right panel), or subjected to cholesterol efflux (h) as described in Methods. (i) Extracts of SMCs isolated from WT, Pak1−/− and ApoE−/− mice fed with CD were analysed by western blotting for the indicated proteins using their specific antibodies. (j) SMCs from WT and Pak1−/− mice fed with CD were treated with OxLDL (10 µg ml−1) for the indicated time periods and RNA was isolated and analysed by qRT–PCR for IL-6 and MCP-1 levels. Bar graph in c represents quantification of three independent experiments. Bar graph in d represents the quantification of three western blottings each from a group of two pooled arteries. Data were presented as mean±s.d. and assessed by Student's t-test. *P<0.01 versus ApoE−/− mice; †P<0.01 versus WT vehicle control; #P<0.01 versus WT mice+OxLDL. Scale bars, 50 µm (a) and 100 and 50 µm (g, left and right panels, respectively).
false
- WB
CiteAb
Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Rao, G. N. et al., 2015, Nat Commun, 26104863. Legend direct from paper.
Pak1 regulates SMC migration and lesion formation.Aortic SMCs from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were isolated, cultured and tested for their purity using anti-SMCα-actin antibodies (a), analysed for IL-6 expression by FACS (b) and subjected to wound-healing migration assay (c). (d) Aortic SMC extracts from ApoE−/− and ApoE−/− : Pak1−/− mice were analysed by western blotting for the indicated proteins using their specific antibodies. FACS analysis of CD36 expression (e) and Dil-OxLDL uptake (f) are shown. SMCs isolated from ApoE−/− and ApoE−/− : Pak1−/− mice fed with WD for 16 weeks were either incubated with OxLDL or Dil-OxLDL for 6 h and stained with Oil red O (g, left panel) or observed under fluorescent microscope (g, right panel), or subjected to cholesterol efflux (h) as described in Methods. (i) Extracts of SMCs isolated from WT, Pak1−/− and ApoE−/− mice fed with CD were analysed by western blotting for the indicated proteins using their specific antibodies. (j) SMCs from WT and Pak1−/− mice fed with CD were treated with OxLDL (10 µg ml−1) for the indicated time periods and RNA was isolated and analysed by qRT–PCR for IL-6 and MCP-1 levels. Bar graph in c represents quantification of three independent experiments. Bar graph in d represents the quantification of three western blottings each from a group of two pooled arteries. Data were presented as mean±s.d. and assessed by Student's t-test. *P<0.01 versus ApoE−/− mice; †P<0.01 versus WT vehicle control; #P<0.01 versus WT mice+OxLDL. Scale bars, 50 µm (a) and 100 and 50 µm (g, left and right panels, respectively).
false
- WB
CiteAb
Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Fernández-Hernando, C. et al., 2016, Nat Commun, 27460411. Legend direct from paper.
ANGPTL4 deficiency promotes macrophage foam cell formation and apoptosis.(a) Representative pictures from WT and Angptl4−/− mouse peritoneal macrophages incubated with or without Ac- LDL (120 µg ml−1) for 24 h and stained with BODIPY 493/503 (1 µg ml−1) and DAPI (Green and blue, respectively). Scale bar, 5 µm. Quantification of the mean average intensity is in the right panel. (b) Total cholesterol content in peritoneal macrophages isolated from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (c) Flow cytometry analysis of DiI-Ox-LDL binding in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 30 min at 4 °C. At the end of the incubation period, cells were washed and incubated in RPMI 10% FBS media for 15 min at 37 °C to allow the internalization. (d) Flow cytometry analysis of DiI-Ox-LDL uptake in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 2 h at 37 °C. The results are expressed in terms of specific MFI after subtracting auto-fluorescence of cells incubated in the absence of DiI-Ox-LDL. (e) Cholesterol efflux to apolipoprotein A1 (ApoA1) in peritoneal macrophages isolated from WT and Angptl4−/− mice stimulated with or without T0901317 (T090). (f) Western blot analysis of indicated proteins in peritoneal macrophages from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (g) Western blot analysis (representative of three blots) of ABCA1 expression in WT and Angptl4−/− peritoneal macrophages incubated with Ac-LDL for 24 h. Surface ABCA1 was isolated using biotinylation followed by incubation with neutravidin. HSP90 is used as loading control (f and g). Full scans of westerns blots are provided in Supplementary Fig. 8. (h) Representative confocal images of mouse peritoneal macrophages from WT and Angptl4−/− mice incubated with Ac-LDL for 24 h and stained with cholera toxin B (CTxB), ABCA1 and DAPI. Quantification of co-localization of CTxB and ABCA1 is on the right panel. Scale bar, 10 µm. (i) Representative images of WT and Angptl4−/− macrophages cultured on coverslips and treated with or without Ac-LDL (120 µg ml−1) in combination with ACAT inhibitor (58035) for 24 h to induce lipid-loading-induced apoptosis (scale bars, 200 µm). Apoptosis was detected using Annexin-V staining. Right panel shows the quantification of percentage of apoptotic cells from four random fields from each cover slip. All data represent the mean±s.e.m. from at least three experiments in duplicate; *P<0.05 compared with WT macrophages by unpaired t-test. MFI, median intensity of fluorescence.
false
- WB
CiteAb
Western blot - Anti-ABCA1 antibody [AB.H10] (AB18180)
Western Blotting using Anti-ABCA1 antibody [AB.H10]Anti-ABCA1 antibody [AB.H10], ab18180. Publication image from Fernández-Hernando, C. et al., 2016, Nat Commun, 27460411. Legend direct from paper.
ANGPTL4 deficiency promotes macrophage foam cell formation and apoptosis.(a) Representative pictures from WT and Angptl4−/− mouse peritoneal macrophages incubated with or without Ac- LDL (120 µg ml−1) for 24 h and stained with BODIPY 493/503 (1 µg ml−1) and DAPI (Green and blue, respectively). Scale bar, 5 µm. Quantification of the mean average intensity is in the right panel. (b) Total cholesterol content in peritoneal macrophages isolated from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (c) Flow cytometry analysis of DiI-Ox-LDL binding in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 30 min at 4 °C. At the end of the incubation period, cells were washed and incubated in RPMI 10% FBS media for 15 min at 37 °C to allow the internalization. (d) Flow cytometry analysis of DiI-Ox-LDL uptake in peritoneal macrophages incubated with DiI-Ox-LDL (30 µg cholesterol per ml) for 2 h at 37 °C. The results are expressed in terms of specific MFI after subtracting auto-fluorescence of cells incubated in the absence of DiI-Ox-LDL. (e) Cholesterol efflux to apolipoprotein A1 (ApoA1) in peritoneal macrophages isolated from WT and Angptl4−/− mice stimulated with or without T0901317 (T090). (f) Western blot analysis of indicated proteins in peritoneal macrophages from WT and Angptl4−/− mice incubated with or without Ac-LDL (120 µg ml−1) for 24 h. (g) Western blot analysis (representative of three blots) of ABCA1 expression in WT and Angptl4−/− peritoneal macrophages incubated with Ac-LDL for 24 h. Surface ABCA1 was isolated using biotinylation followed by incubation with neutravidin. HSP90 is used as loading control (f and g). Full scans of westerns blots are provided in Supplementary Fig. 8. (h) Representative confocal images of mouse peritoneal macrophages from WT and Angptl4−/− mice incubated with Ac-LDL for 24 h and stained with cholera toxin B (CTxB), ABCA1 and DAPI. Quantification of co-localization of CTxB and ABCA1 is on the right panel. Scale bar, 10 µm. (i) Representative images of WT and Angptl4−/− macrophages cultured on coverslips and treated with or without Ac-LDL (120 µg ml−1) in combination with ACAT inhibitor (58035) for 24 h to induce lipid-loading-induced apoptosis (scale bars, 200 µm). Apoptosis was detected using Annexin-V staining. Right panel shows the quantification of percentage of apoptotic cells from four random fields from each cover slip. All data represent the mean±s.e.m. from at least three experiments in duplicate; *P<0.05 compared with WT macrophages by unpaired t-test. MFI, median intensity of fluorescence.
false
Reactivity data
Product details
Anti-ABCA1 antibody [AB.H10] (ab18180) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human, Mouse samples.
What is the molecular weight of ABCA1?
Anti-ABCA1 [AB.H10] (ab18180) specifically detects a band for ABCA1 (UniProt: O95477) at a molecular weight of 254kDa.
Trusted by the scientific community
Anti-ABCA1 [AB.H10] (ab18180) was first used in a scientific publication in 2005 and has been cited over 200 times in peer-reviewed journals.
Reviewed by scientists
Anti-ABCA1 [AB.H10] (ab18180) has over 15 independent reviews from customers.
Specificity confirmed
The specificity of Anti-ABCA1 antibody [AB.H10] (ab18180) has been confirmed by Western blot testing in ABCA1 Knockout Mouse liver samples.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ABCA1 functions as a cholesterol efflux pump in the cellular membrane. It facilitates the transfer of cholesterol to lipid-poor apolipoproteins such as apoA-I which then forms HDL particles. This active process helps maintain cellular cholesterol homeostasis and reduces cholesterol accumulation. ABCA1 is a critical component of the HDL synthesis pathway and does not form part of a larger protein complex acting more as an individual unit in this function.
Pathways
Many regulatory mechanisms control the activity of ABCA1. It plays a significant role in the reverse cholesterol transport pathway thereby promoting the movement of cholesterol away from peripheral tissues back to the liver for excretion. This pathway helps maintain systemic lipid balance. The LXR/RXR pathway regulates ABCA1 expression aligning it closely with other proteins such as LXR and ABCG1 which also deal with cholesterol metabolism.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (244)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8077 PubMed40883260
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of atherosclerosis and thrombosis : PubMed40850750
2025
Applications
Unspecified application
Species
Unspecified reactive species
Food & nutrition research 69: PubMed40475061
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mechanobiology in medicine 3:100129 PubMed40395775
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 17: PubMed40292571
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:193 PubMed40268915
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 82:131 PubMed40137979
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular neurodegeneration 20:15 PubMed39901180
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 182:1763-1782 PubMed39843165
2025
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 78:103427 PubMed39566163
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com